drugset / Trial / NCT00655746
The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to assess the effect of omeprazole on the pharmacokinetics of dasatinib in healthy subjects and to assess the safety and tolerability of a single dose of dasatinib before and after 5 days of dosing with omeprazole in healthy subjects
Timeline
- Start
- 2008-04
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 40 mg | Oral |
| Subject | dasatinib anhydrous | Small molecule | 100 mg | Oral |
Indications
No indication recorded.